Neurology
While Cures Within Reach is disease-agnostic, we are dedicated to improving the quality and length of life for patients living with a neurological disease (mental health, neurodegenerative or pain) through the speed and cost-effectiveness of medical repurposing.
Our events and research within the Neurology Repurposing Community all focus on connecting our many stakeholder groups together in our shared goal: driving more treatments to more patients more quickly through repurposing.
Funding Opportunity RFPs for Neurology:
- US Based Repurposing Clinical Trials to Address Health Equity 2024: INVITE ONLY accepting budgets of up to $75,000 for repurposing clinical trials to address health equity, including repurposing clinical trials that EITHER are 1) led by an underrepresented researcher OR 2) address health disparities among underrepresented patients OR 3) both 1) and 2). PROPOSAL DEADLINE CLOSED; SUBMISSIONS UNDER REVIEW
- Read about our open RFP for Repurposing Research for Chicago: Chicago-based neurology clinical trials are eligible! Accepting budgets of up to $100,000 for clinical repurposing trials from Chicago area research institutions in one or more of the following tracks. LOI DEADLINE CLOSED; SUBMISSIONS UNDER REVIEW
- Track 1 – Diversity, Equity and Inclusion: clinical repurposing trials that 1) are led by an underrepresented researcher (as defined by the NIH) OR 2) address health disparities among underrepresented patients (as defined by the NIH) OR both 1) and 2).
- Track 2 – Early Stage Investigators: clinical repurposing trials in any unsolved disease led by a researcher who is within 10 years of completing an advanced degree or medical residency.
- Track 3 – Pediatrics: clinical repurposing trials to address unmet medical needs of pediatric patients, including adding a pediatric arm to an adult clinical repurposing trial.
- Track 4 – Veterans/Military: clinical repurposing trials to address unmet medical needs of US veterans and/or active US military, including but not limited to mental health, post-traumatic stress disorder (PTSD) and brain injuries.
- Read about our open RFP for ReGRoW: Funding for Underresourced Researchers in Low and Lower-Middle Income Countries: clinical trials in neurology are eligible! Accepting budgets of up to $65,000 for clinical repurposing trials in any disease led by an underresourced researcher in any LMIC, as defined by the World Bank. LOI DEADLINE CLOSED; SUBMISSIONS UNDER REVIEW
- Read about our open RFP for Clinical Repurposing Research to Impact Veterans/Military: clinical trials in neurology are eligible! Accepting budgets of up to $75,000 to a U.S.-based institution for a repurposing clinical trial in any disease area impacting veterans or active military, such as mental health, PTSD and brain injuries. LOI DEADLINE CLOSED; SUBMISSIONS UNDER REVIEW
More information on our Funding Opportunities / RFPs page.
Our ongoing neurology trials:
Current Neuro Trials
Neuro: Completed Trials and Press Releases
(in the past 3 years)
Events
Diversity of Clinical Trial Researchers and Patients: A Repurposing Opportunity?
November 2021
Virtual
A dialogue on the dual opportunities of clinical trial diversity to impact health disparities and/or improve minority leadership in scientific research.
Real World Data Through a Patient’s Lens
October 2021
Virtual
A conversation on Real World Data (RWD) and case reports from clinicians and researchers.
Repurposing for Pediatric Patients: Best Practices and Lessons Learned
November 2020
Virtual
A patient-focused conversation on the opportunities that repurposing drugs, devices and other treatments provide for the pediatric patient population.
How Patients Impact the 505(b)(2) Regulatory Process
October 2020
Virtual
A patient-focused conversation on the 505(b)(2) regulatory process and how patients, caregivers and patient advocacy groups can engage with both industry and regulators to support the drug development process, share their real-world perspectives for clinical trial planning and represent the patient view throughout the drug approval process.
CureAccelerator Live for Chicago 2020
September 2020
Virtual
Four finalists from the greater Chicago area competing for up to $50,000 to fund their repurposing clinical trials.
Repurposing Drugs for Alzheimer’s Disease
November 2019
New York, NY
In conjunction with the Alzheimer’s Drug Discovery Foundation, a patient education panel of renowned scientists discussing the role of repurposing in treating Alzheimer’s disease, during ADDF’s annual Hope on the Horizon event.
CureAccelerator Live! for the Mid-Atlantic 2018
October 2018
Washington, DC
Four finalists from Mid-Atlantic institutions competing for up to $50,000 to fund their groundbreaking repurposing clinical trials.
Latest News
- Helius Medical Technologies Receives Medical Device License Clearance from Health Canada for PoNS™ Device
- Too Much Stress Will Literally Shrink Your Brain, Experts Warn
- What 'This Is Us' gets right about depression
- Randomized Placebo-Controlled Trial of Nabilone for Agitation in Alzheimer's Disease
- Alzheimer's Matters Blog TOP 5 ADVANCES IN 2018
- Cannabis-like drug may ease agitation in Alzheimer's patients
- ALZHEIMER’S TRIAL WILL “BATHE” PATIENTS’ BRAINS IN HELPFUL GENES
- Impact of Repurposing on Patients
- Opportunity That Clinical Repurposing Trials Brings to Patients
- How Your Donation to Cures Within Reach Creates Real Patient Impact
- Cures Within Reach Funds Huntington’s Disease Clinical Trial with Nilotinib at Georgetown
- Podcast: Impact Philanthropy Accelerating Cures Within Reach
Community Members
